Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The cell lysis and disruption market was valued at USD 5.33 Billion in 2025, driven by growing demand in biopharmaceutical and biotechnology industries. The market is anticipated to grow at a CAGR of 8.90% during the forecast period of 2026-2035, with values likely to reach USD 12.50 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
8.9%
Value in USD Billion
2026-2035
*this image is indicative*
This growth is due to the increased adoption of methods of cell lysis and disruption during downstream processing to produce bio-therapeutics and other recombinant products based on animals.
Cell lysis refers to the breaking down of a cell membrane, often through viral, enzyme, or osmotic mechanisms that threaten its integrity. A liquid that includes lysed cell contents is called a lysate. Cell disruption is a mechanism or system by which biological molecules can be released from within a cell.
Market Breakup by Product
Market Breakup by Cell Type
Market Breakup by Application
Market Breakup by End Use
Market Breakup by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing investments in research and development related to biotechnological processes by various government and private organizations and academics are anticipated to drive the market forward significantly. Furthermore, the increase in the prevalence of different disorders and the demand for new therapies are expected to stimulate the market growth. It is expected that the adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries will drive the market growth as cell lysis plays a significant role in the bioprocesses.
The report presents a detailed analysis of the following key players in the global cell lysis & disruption market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market was valued at USD 5.33 Billion in 2025.
The market is anticipated to grow at a CAGR of 8.90% during the forecast period of 2026-2035, with the values likely to reach USD 12.50 Billion by 2035.
The major drivers of the market include the increased adoption of methods of cell lysis and disruption during downstream processing to produce bio-therapeutics and other recombinant products based on animals.
The increase in the prevalence of different disorders and the demand for new therapies are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The two major product types of cell lysis and disruption are instruments, and reagents and consumables. Instruments can be further divided into high pressure homogenizers, sonicator, French press, microfluidizer, and bead mill, among others. Reagents and consumables are further categorised into enzymes, detergent solutions, ionic detergent, non-ionic detergent, zwitterionic detergent, and kits and reagents, among others.
The leading application segments of the industry include protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation.
The market is divided on the basis of cell type into mammalian cells, bacterial cells, yeast/algae/fungi, and plant cells.
The end use sectors for the industry are academic and research institutes, hospitals and diagnostic labs, cell banks, pharmaceutical and biotechnology companies.
The major players in the industry are Thermo Fisher Scientific Inc. (NYSE: TMO), Becton, Dickinson and Company (NYSE: BDX), Bio-Rad Laboratories, Inc. (NYSE: BIO), Miltenyi Biotec B.V. & Co. KG, Qiagen GmbH, Merck KGaA (FWB: MRK), and F. Hoffmann-La Roche Ltd. (SWX: ROG), among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Cell Type |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share